Andrews William T.
Insider CIK 1638459 · ACER Chief Medical Officer · AEGR See Remarks · CPRX Chief Medical Officer · FLXN Chief Medical Officer · AKCA Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 29,776 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 12,209 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 98,652 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 124,447 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer | 2026-07-15 | 2026-07-17 | 2,309 | $31.50 | $72.7K | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2026-06-03 | 2026-06-05 | 743 | — | $0 | 2,309 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2026-06-03 | 2026-06-05 | 3,052 | — | $0 | 3,052 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 29,776 | — | $0 | 268,136 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 98,652 | — | $0 | 238,360 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-06-03 | 2026-06-05 | 3,052 | — | $0 | 240,195 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 205,500 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer | 2021-11-19 | 2021-11-19 | 34,250 | $8.50 | $291.1K | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2021-08-02 | 2021-08-04 | 205,500 | — | $0 | 205,500 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award | 2021-08-02 | 2021-08-04 | 34,250 | — | $0 | 34,250 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | D To issuer deriv | 2020-10-12 | 2020-10-13 | 250,000 | $4.86 | $1.22M | 0 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | U Tender | 2020-10-12 | 2020-10-13 | 37,500 | $18.15 | $680.6K | 0 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award deriv | 2020-07-09 | 2020-07-10 | 250,000 | — | $0 | 250,000 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award | 2020-07-09 | 2020-07-10 | 37,500 | — | $0 | 37,500 | SEC↗ |
| ACER Acer Therapeutics Inc. | F Tax w/h | 2020-03-02 | 2020-03-04 | 3,142 | $3.28 | $10.3K | 5,858 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2019-09-18 | 2019-09-23 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award | 2019-03-01 | 2019-03-05 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2019-02-01 | 2019-02-05 | 27,000 | — | $0 | 27,000 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2017-10-04 | 2017-10-06 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-08-04 | 2015-08-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-04-01 | 2015-04-03 | 27,000 | — | $0 | 27,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-04-01 | 2015-04-03 | 7,000 | — | $0 | 7,000 | SEC↗ |